Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 10/20 | 0.81 |
| ▸ | THRB | P10828 | 10/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.81 |
| ▸ | BLM | P54132 | 9/20 | 0.81 |
| ▸ | RECQL | P46063 | 8/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.81 |
| ▸ | MAPT | P10636 | 7/20 | 0.81 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.81 |
| ▸ | BRCA1 | P38398 | 6/20 | 0.81 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.81 |
| ▸ | TOP2A | P11388 | 5/20 | 0.81 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.81 |
| ▸ | HTT | P42858 | 5/20 | 0.81 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.81 |
| ▸ | STAT6 | P42226 | 4/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.81 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.81 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.81 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Detorubicin SCHEMBL29771309 | 1.00 | MEN1 (0.81) | MEN1THRBKMT2ABLMRECQL | |
| Detorubicin SCHEMBL27821471 | 1.00 | MEN1 (0.81) | MEN1THRBKMT2ABLMRECQL | |
| SCHEMBL14547833 | 0.92 | MEN1 (0.80) | MEN1THRBKMT2ABLMRECQL | |
| SCHEMBL14547744 | 0.92 | MEN1 (0.80) | MEN1THRBKMT2ABLMRECQL | |
| SCHEMBL14524971 | 0.92 | MEN1 (0.84) | MEN1THRBKMT2ABLMRECQL | |
| SCHEMBL14867452 | 0.92 | MEN1 (0.84) | MEN1THRBKMT2ABLMRECQL | |
| SCHEMBL13742595 | 0.92 | MEN1 (0.88) | MEN1THRBKMT2ABLMRECQL | |
| SCHEMBL22513656 | 0.92 | MEN1 (0.88) | MEN1THRBKMT2ABLMRECQL | |
| SCHEMBL20801118 | 0.92 | MEN1 (0.88) | MEN1THRBKMT2ABLMRECQL | |
| SCHEMBL17899481 | 0.92 | MEN1 (0.88) | MEN1THRBKMT2ABLMRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 22600 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12606536-B2 | Bioactive phenolate ionic complexes | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2026-04-21 | — | — | US | claimed |
| US-20260085100-A1 | METHODS OF ANTIGEN PRODUCTION | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2026-03-26 | — | — | US | claimed |
| US-20260077056-A1 | LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4698185-A1 | METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES | Osasuna Therapeutics SA (CH) | 2026-02-25 | — | — | EP | claimed |
| US-5622929-A | ANTHRACYCLINE ANTIBIOTIC; ANTITUMOR AGENT BINDS WITH A TARGET CELL | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-04-22 | — | — | US | claimed |
| EP-0398305-B1 | Anthracycline conjugates having a novel linker and methods for their production | BRISTOL MYERS SQUIBB CO (US) | 1997-03-19 | — | — | EP | claimed |
| US-5606017-A | ANTITUMOR AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-02-25 | — | — | US | claimed |
| EP-0328147-B1 | Anthracycline immunoconjugates having a novel linker and methods for their production | BRISTOL MYERS SQUIBB CO (US) | 1994-05-11 | — | — | EP | claimed |
| EP-0554708-A1 | Thioether conjugates | Bristol-Myers Squibb Company (US) | 1993-08-11 | — | — | EP | claimed |
| US-5137877-A | N-substituted hydrazine bifuctional derivative; cytotoxic reagent | BRISTOL-MYERS SQUIBB (US) | 1992-08-11 | — | — | US | claimed |
| US-5122368-A | Bound to linker arm by an acid-sensitive hydrazone at the keto on C#13 and thiolated antibodies; target cells; anticarcinogenic and -tumor agents; drug delivery | BRISTOL-MYERS SQUIBB COMPANY (US) | 1992-06-16 | — | — | US | claimed |
| EP-0457250-A2 | Novel bifunctional linking compounds, conjugates and methods for their production | BRISTOL-MYERS SQUIBB COMPANY (US) | 1991-11-21 | — | — | EP | claimed |
| EP-0398305-A2 | Anthracycline conjugates having a novel linker and methods for their production | Bristol-Myers Squibb Company (US) | 1990-11-22 | — | — | EP | claimed |
| EP-0328147-A2 | Anthracycline immunoconjugates having a novel linker and methods for their production | Bristol-Myers Squibb Company (US) | 1989-08-16 | — | — | EP | claimed |